FDA scientists from across the agency have given presentations on topics related to advancing alternative methods.  The list below is current and updated regularly. 


Advancing Alternatives at FDA, given by Donna L. Mendrick, Ph.D.
at the IUTOX panel discussion at the Society of Toxicology Annual Meeting on March 16, 2021

FDA, ICH, and the 3Rs, September 2020

Microphysiological Systems (MPS): Bridging Human and Animal Research - An FDA/CDER Perspective given by Amy Avila, PhD

Microphysiological Systems to Assess the Functional Capacity of Cellular Therapy Products

Predicting the Effects of Candidate Drugs: The Future, given by Janet Woodcock, M.D.
Nov. 18, 2020 at the American College of Toxicology Annual Meeting

Resources for You

Advancing Alternative Methods at FDA

FDA's Predictive Toxicology Roadmap